RxDoctor Payments Data

Teresa Templin, NP

Family · Converse, INNPI 1750362406

Payments from drug & device makers

$513in general payments, 2019–2025

Across 32 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$107
  • AbbVie$72
  • Medtronic$65
  • AstraZeneca$57
  • Axsome Therapeutics, Inc.$54
  • Exact Sciences$36
  • plus $121 from 5 others

What the payments were for

  • Food & beverage$513100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$513 in reported general payments places this provider in the 55th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$57,254
Medicare patients
174
Services billed
1,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$41,811
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$31,103
MounjaroTirzepatide17$21,926
JardianceEmpagliflozin21$18,944
Breo ElliptaFluticasone/Vilanterol24$14,704
Spiriva HandihalerTiotropium Bromide13$6,584
Colesevelam Hcl23$3,591
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,219
Atorvastatin Calcium280$2,202
Levothyroxine Sodium228$1,922
SynthroidLevothyroxine Sodium22$1,771
Albuterol Sulfate HfaAlbuterol Sulfate50$1,381
Metoprolol Succinate110$1,171
Losartan Potassium148$1,139
FenofibrateFenofibrate Nanocrystallized33$1,053

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$33$21,92617 claims
Boehringer IngelheimJardiance$19$18,94421 claims
AbbVieSynthroid$72$1,77122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,392 family providers in Indiana.

Other family in Converse

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →